Indivior PLC(INDV)
Search documents
Indivior PLC(INDV) - 2024 Q3 - Earnings Call Transcript
2024-10-24 18:02
Indivior PLC (NASDAQ:INDV) Q3 2024 Earnings Conference Call October 24, 2024 8:00 AM ET Company Participants Jason Thompson - Head, IR Mark Crossley - CEO Christian Heidbreder - Chief Scientific Officer Ryan Preblick - CFO Conference Call Participants David Amsellem - Piper Sandler Chase Knickerbocker - Craig-Hallum Paul Cudden - Deutsche Numis Christian Glennie - Stifel Operator Good day and thank you for standing by. Welcome to the Indivior PLC Third Quarter 2024 Conference Call. At this time, all partici ...
Indivior PLC(INDV) - 2024 Q3 - Earnings Call Presentation
2024-10-24 13:53
张INDIVIOR Q3 2024 Results October 24, 2024 Q3 2024 Results | October 24, 2024 2 Important Cautionary Statement Regarding Forward-looking Statements This presentation contains certain statements that are forward-looking. Forward-looking statements include, among other things, express and implied statements regarding: strategic priorities, strategies for value creation, and operational goals; expected future growth and the timing and amount of sales of particular products; the Indivior Group's financial guida ...
Indivior PLC(INDV) - 2024 Q3 - Quarterly Report
2024-10-24 13:16
October 24, 2024 Q3 and YTD 2024 Financial Results • Total Q3 2024 net revenue (NR) of $307m, +13% vs. Q3 2023 • SUBLOCADE® Q3 2024 NR of $191m, +14% vs. Q3 2023; YTD 2024 SUBLOCADE NR of $562m, +24% vs. YTD 2023 • Expected settlement reached with certain end payors to resolve remaining antitrust cases | --- | --- | --- | --- | --- | --- | --- | |--------------------------------------------|------------|------------|----------|-------------|-------------|----------| | Period to September 30th (Unaudited) | ...
October 1, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against INDV
Prnewswire· 2024-09-23 09:45
NEW YORK, Sept. 23, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Indivior PLC (NASDAQ: INDV). Shareholders who purchased shares of INDV during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/indivior-loss-submission-form/?id=104033&from=4 CLASS PERIOD: February 22, 2024 to July ...
INVESTOR ALERT: DiCello Levitt LLP Shareholder Class Action Lawsuit Filed Against Indivior PLC (NASDAQ: INDV); Investors with Losses Encouraged to Discuss Their Options with Counsel
GlobeNewswire News Room· 2024-09-14 00:09
SAN DIEGO, Sept. 13, 2024 (GLOBE NEWSWIRE) -- A class action lawsuit has been filed on behalf of purchasers or acquirers of Indivior PLC (NASDAQ: INDV) ("Indivior" or the "Company") securities between February 22, 2024 and July 8, 2024, inclusive (the "Class Period"), charging the Company and certain senior executives with violations of the federal securities laws (collectively, "Defendants"). Indivior investors have until October 1, 2024, to seek appointment as lead plaintiff of the Indivior class action l ...
Indivior PLC(INDV) - 2024 Q2 - Earnings Call Transcript
2024-07-25 18:54
Indivior PLC (NASDAQ:INDV) Q2 2024 Earnings Conference Call July 25, 2024 8:30 AM ET Company Participants Jason Thompson - VP, IR Mark Crossley - CEO Christian Heidbreder - Chief Scientific Officer Ryan Preblick - CFO Conference Call Participants David Amsellem - Piper Sandler Paul Cudden - Deutsche Numis Chase Knickerbocker - Craig-Hallum Thibault Boutherin - Morgan Stanley Max Herrmann - Stifel Operator Good day, and thank you for standing by. Welcome to the Indivior PLC Half Year Results 2024 Conference ...
Indivior PLC(INDV) - 2024 Q2 - Quarterly Report
2024-07-25 10:20
July 25, 2024 Q2 2024 Results In Line with Updated Guidance; $100m Share Buyback Announced • Reports Q2 2024 SUBLOCADE® Net Revenue (NR) of $192m (+24% versus Q2 2023) • Announces new $100m share repurchase program • Announces expected settlement of certain opioid litigation (See Notes 11 and 13). THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 (AS IT FORMS PART OF DOMESTIC LAW IN THE UK BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT ...
Indivior Announces a New $100 Million Share Repurchase Program; New Program will be Executed Over an Accelerated Time Frame
Prnewswire· 2024-07-25 06:10
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 (AS IT FORMS PART OF DOMESTIC LAW IN THE UK BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018). RICHMOND, Va., July 25, 2024 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV) ("Indivior" or the "Company"), a leading addiction treatment company, today announced that its Board of Directors has approved a new share repurchase program under which the Company will commence repurchasing Indiv ...
Indivior PLC (INDV) Business Update Call Transcript
2024-07-09 14:39
Indivior PLC (NASDAQ:INDV) Business Update Conference Call July 9, 2024 8:00 AM ET Company Participants Jason Thompson - VP, IR Mark Crossley - CEO Conference Call Participants Max Herrmann - Stifel Thibault Boutherin - Morgan Stanley Paul Cuddon - Deutsche Numis Chase Knickerbocker - Craig-Hallum Carl Byrnes - Northland Capital Markets Operator Good day, and thank you for standing by. Welcome to the Indivior Business Update Conference Call. At this time all participants are in listen-only mode. After the s ...
Indivior Provides Business Update; Conference Call at 8:00 AM U.S. EDT
Prnewswire· 2024-07-09 06:00
Separately, we are taking decisive action that we believe is in the best interest of shareholders in two areas. First, we are creating greater certainty for all stakeholders by settling with Plaintiffs ahead of our antitrust trial on July 15th. Second, due to anticipated increased payor management of the category that makes PERSERIS' future no longer financially viable, we have determined to take the required actions to discontinue the product. While we believe discontinuing PERSERIS is the right business d ...